ELVN icon

Enliven Therapeutics
ELVN

Overview Fund Activity

124 hedge funds and large institutions have $1.19B invested in Enliven Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 57 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
+3
Holders Change %
+2.48%
% of All Funds
1.66%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
24
Increased
57
Reduced
23
Closed
20
Calls
–
Puts
$14K
Net Calls
-$14K
Net Calls Change
+$3K

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$26.4M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.3M
3
NHAS
Novo Holdings A/S
Denmark
+$21.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.1M
5
PCH
Polar Capital Holdings
United Kingdom
+$13.7M

Top Sellers

1
BCM
Boxer Capital Management
California
-$13.2M
2
5VM
5AM Venture Management
California
-$11M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.1M
4
IC
Ikarian Capital
Texas
-$5.7M
5
ACP
Acuta Capital Partners
California
-$5.22M
Name Holding Trade Value Shares
Change 		Shares
Change %
Franklin Resources
26
Franklin Resources
California
$8.63M +$8.23M +410,034 +2,029%
CS
27
Candriam SCA
Luxembourg
$8.36M +$8.36M +416,650 New
AAA
28
Affinity Asset Advisors
New York
$8.02M +$8.02M +400,000 New
LGM
29
Logos Global Management
California
$7.02M +$2.21M +110,000 +46%
Marshall Wace
30
Marshall Wace
United Kingdom
$6.69M +$6.46M +322,173 +2,887%
Northern Trust
31
Northern Trust
Illinois
$6.51M -$281K -14,022 -4%
Millennium Management
32
Millennium Management
New York
$6.39M +$3.72M +185,562 +140%
Charles Schwab
33
Charles Schwab
California
$6.13M +$925K +46,123 +18%
ABG
34
Ally Bridge Group
New York
$5.64M +$2.24M +111,620 +66%
Morgan Stanley
35
Morgan Stanley
New York
$5.11M +$3.48M +173,533 +213%
VPC
36
Vestal Point Capital
New York
$5.02M +$5.02M +250,000 New
PSC
37
Patient Square Capital
California
$4.93M -$160K -8,000 -3%
CAM
38
Cormorant Asset Management
Massachusetts
$4.01M -$1M -50,000 -20%
Goldman Sachs
39
Goldman Sachs
New York
$3.8M -$446K -22,247 -11%
HS
40
HighVista Strategies
Massachusetts
$2.84M +$583K +29,057 +26%
UBS Group
41
UBS Group
Switzerland
$2.77M +$1.36M +67,844 +96%
SFM
42
Sphera Funds Management
Israel
$2.58M +$336K +16,772 +15%
BBA
43
Baker Bros. Advisors
New York
$2.3M – – –
Bank of New York Mellon
44
Bank of New York Mellon
New York
$1.97M +$91.5K +4,562 +5%
Adage Capital Partners
45
Adage Capital Partners
Massachusetts
$1.93M -$7.1M -354,000 -79%
Wellington Management Group
46
Wellington Management Group
Massachusetts
$1.89M +$187K +9,312 +11%
NL
47
Nuveen LLC
North Carolina
$1.8M -$289K -14,387 -14%
UBS AM
48
UBS AM
Illinois
$1.67M +$946K +47,156 +131%
Barclays
49
Barclays
United Kingdom
$1.46M +$450K +22,427 +45%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$1.36M +$1.26M +62,688 +1,211%
1
2
3 4 5